A study in Diabetic Medicine showed that plasma glucose challenge testing provided more accurate results for diabetes and high-risk dysglycemia detection and was cheaper, compared with A1C, random capillary glucose and random plasma glucose testing methods. Researchers analyzed data from 1,535 patients in a Veterans Health Administration primary care clinic and also found that capillary glucose challenge testing detected diabetes and high-risk dysglycemia more accurately than A1C and random capillary glucose testing.
Healio (free registration)/Endocrine Today (10/21)
News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.